These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2138994)

  • 41. Autologous bone marrow transplantation in acute myeloid leukemia in first remission: first Dutch prospective study.
    Löwenberg B; van Putten WL; Verdonck LF; Dekker AW; de Gast GC; Willemze R; Zwaan FE; Abels J; Sonneveld P; van der Lelie J
    Haematol Blood Transfus; 1990; 33():655-60. PubMed ID: 2182456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
    Schiller G; Gajewski J; Lee M; Ho W; Territo M; Champlin R
    Leuk Lymphoma; 1994 Sep; 15(1-2):85-90. PubMed ID: 7858506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Childhood acute myeloblastic leukemias. Report of 21 cases].
    Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
    Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
    Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
    Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-dose cytarabine for intensification of early therapy of childhood acute myeloid leukemia: a Pediatric Oncology Group study.
    Ravindranath Y; Steuber CP; Krischer J; Civin CI; Ducore J; Vega R; Pitel P; Inoue S; Bleher E; Sexauer C
    J Clin Oncol; 1991 Apr; 9(4):572-80. PubMed ID: 2066754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Autologous bone marrow transplantation in patients with AML in second complete remission (CR).
    Meloni G; De Fabritiis P; Amadori S; Petti MC; Pulsoni A; Sandrelli A; Mandelli F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():207-8. PubMed ID: 2653505
    [No Abstract]   [Full Text] [Related]  

  • 47. Autologous bone marrow transplant in acute myeloid leukemia in first remission.
    Cassileth PA; Andersen J; Lazarus HM; Colvin OM; Bennett JM; Stadtmauer EA; Kaizer H; Weiner RS; Edelstein M; Oken MM
    J Clin Oncol; 1993 Feb; 11(2):314-9. PubMed ID: 8426209
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short term therapy (STT) for acute myelogenous leukaemia (AML).
    Rohatiner AZ; Battista R; Bassan R; Love S; Oza AM; Whelan JS; Lim J; Buelli M; Viero P; D'Emillio A
    Leukemia; 1992; 6 Suppl 2():85-8. PubMed ID: 1578952
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Second long-term remission achieved with low-dose Ara-C in children with relapsed acute nonlymphoblastic leukemia.
    Miniero R; Saracco P; Cordero di Montezemolo L; Fiandino G; Comelli A; Madon E
    Pediatr Hematol Oncol; 1987; 4(3):273-6. PubMed ID: 3152932
    [No Abstract]   [Full Text] [Related]  

  • 50. The impact of early intensive therapy on event-free survival (EFS) in children with acute myeloid leukemia (AML).
    Weinstein H; Ravindranath Y; Krischer J; Steuber P; Civin C; Gresik M; Vietti T
    Leukemia; 1992; 6 Suppl 2():52-4. PubMed ID: 1578941
    [No Abstract]   [Full Text] [Related]  

  • 51. In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remission.
    Stein AS; O'Donnell MR; Chai A; Schmidt GM; Nademanee A; Parker PM; Smith EP; Snyder DS; Molina A; Stepan DE; Spielberger R; Somlo G; Margolin KA; Vora N; Lipsett J; Lee J; Niland J; Forman SJ
    J Clin Oncol; 1996 Aug; 14(8):2206-16. PubMed ID: 8708709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intermediate and high dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase II study.
    Willemze R; Jager U; Jehn U; Stryckmans P; Bury J; Suciu S; Solbu G; Zittoun R; Burghouts J; Löwenberg B
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1721-5. PubMed ID: 3061827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of antifungal therapy on hematological recovery after intensive antileukemic chemotherapy.
    Essink ME; Hiddemann W; von Eiff M; Büchner T; van de Loo J
    Haematol Blood Transfus; 1990; 33():558-9. PubMed ID: 2323655
    [No Abstract]   [Full Text] [Related]  

  • 54. Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia.
    Palle J; Frost BM; Petersson C; Hasle H; Hellebostad M; Kanerva J; Schmiegelow K; Lönnerholm G;
    Anticancer Drugs; 2009 Jan; 20(1):7-14. PubMed ID: 19342996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-dose arabinosyl cytosine therapy of AML may be effective after failure of high or conventional doses.
    Tertian G; Tchernia G; Léonard C; Miélot F; Avalos M; Mirica C; Brivet F; Dommergues JP
    Nouv Rev Fr Hematol (1978); 1989; 31(4):311-3. PubMed ID: 2608442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission.
    Dahl GV; Kalwinsky DK; Mirro J; Look AT; Pui CH; Murphy SB; Mason C; Ruggiero M; Schell M; Johnson FL
    J Clin Oncol; 1990 Feb; 8(2):295-303. PubMed ID: 2299372
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of bone marrow cells grown in long-term culture for autologous bone marrow transplantation in acute myeloid leukaemia: an update.
    Chang J; Morgenstern GR; Coutinho LH; Scarffe JH; Carr T; Deakin DP; Testa NG; Dexter TM
    Bone Marrow Transplant; 1989 Jan; 4(1):5-9. PubMed ID: 2647188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Principal results of the Medical Research Council's 8th acute myeloid leukaemia trial.
    Rees JK; Gray RG; Swirsky D; Hayhoe FG
    Lancet; 1986 Nov; 2(8518):1236-41. PubMed ID: 2878130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821.
    Chang M; Raimondi SC; Ravindranath Y; Carroll AJ; Camitta B; Gresik MV; Steuber CP; Weinstein H
    Leukemia; 2000 Jul; 14(7):1201-7. PubMed ID: 10914543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose cytarabine in consolidation chemotherapy or with bone marrow transplantation for patients with acute leukemia: preliminary results.
    Champlin R; Jacobs A; Gale RP; Ho W; Selch M; Lenarsky C; Feig SA
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):190-5. PubMed ID: 3892702
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.